Cell Line Development Market

Cell Line Development Market: Reagents and Media Segment Anticipated to be the Most Attractive During the Forecast Period: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028

2018-10-26
REP-GB-7566
329 pages

Home
Market Research Reports
Healthcare, Pharmaceuticals and Medical devices
Cell Line Development Market

An Incisive, In-depth Analysis on the Cell Line Development Market

This study offers a comprehensive, 360 degree analysis on the Cell Line Development market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Cell Line Development market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample

Ask An Analyst

Request Special Price

Request Methodology

60% revenue contribution of leading manufacturers

Companies like GE Healthcare, Thermo Fischer Scientific, Inc., Danaher and Merck KGaA have promising revenue share in cell line development market. These companies are endeavoring to launch novel product line in cell line development market. Companies operating in cell line development market are focusing on merger and acquisition strategies to expand their portfolio in cell line development. To expand in the cell line development market, the companies are working in collaboration with local wholesalers and distributors. In cell line development market, the local companies are contending based on pricing and effective channel management in the cell line development market.

Government organizations focusing more on drug discovery and development

In the search of new treatment pathway for the diseases like cancer and neurological disorder, researcher are focusing on cell biology and in-vitro cell culture. Furthermore government activities pertaining to development of biologics, and vaccines and growing awareness relating to monoclonal antibodies application in oncology, auto-immune diseases are expected to drive the growth of provincial business in cell line development market. In developing countries several government initiatives such as improvement in healthcare infrastructure and launch of public healthcare programs leads the growth of biotechnology sector thereby boosting the growth cell line development market

Regenerative medicines – the next generation treatment solution

Regenerative medicines deals with the process to regrow, repair and replace damaged and diseased cells, tissues, and organs which has been lost due to age, disease, damage, or congenital defects. Regenerative medicines are the next generation treatment solution and Cell Line Development is an invariable part of regenerative medicine. For example stem cells are used as a tool in regenerative medicines. Adult stem cells are easily available in human body and are used to stem cells to repair itself. Adult stem cells can be collected from cord blood, bone marrow, dental pulp and other sources. Thus, the introduction of novel product line in regenerative medicine segment is anticipate to increase the demand for cell line development during the forecast period.

Increasing demand for biopharmaceuticals

Biopharmaceuticals therapeutic drugs are manufactured through genetic manipulation of organism or living cells. Additionally patent expiry of branded therapeutics leads to increase in development of biosimilars thereby increase the revenue opportunity in overall cell line development market. The growing use of biological therapeutics in treating chronic diseases, like cancer, arthritis diabetes and rare diseases are majorly influencing the development of biopharmaceuticals. Additionally, the appearance of high-expressing cell lines is further boosting the growth of cell line development market.

Increasing focus on cancer research

Cell based assay involving in vitro cancer cell culture are required for cancer research and development activities. National Cancer Institute (NCI) alongside different organizations invests in R&D activities to encourage and bolster the cancer research. For example, Cancer Moonshot, The RAS Initiative, National Clinical Trials Network (NCTN), NCI Community Oncology Research Program (NCORP), NCI Genomic Data Commons (GDC) and so on. Such government and non-government organization’s initiatives on cancer research positively impacting the Cell Line Development Market.

Increase in outsourcing by pharmaceutical and biotechnological companies

The biotechnological and pharmaceutical companies are focusing on outsourcing their research and development operation to different contract research organizations (CROs). The rising global cost pressure on governments for cost effective biopharmaceuticals and changing political scenario across the globe forced these companies to take engaged into development of novel, cost effective biological products. Moreover various CROs are predominantly using in-vitro cell culture to increase the production of biologics and biopharmaceuticals which is anticipate to increase the demand for cell line development market. Cell Line Development market would pre-dominated by biopharmaceutical contract manufacturing companies. Both industrial and research verticals are in search of better and advanced cell lines to develop novel therapeutic proteins, drugs, vaccines, and biosimilars. This has led to a better prospect for growth of cell line development market over the forecast period.

Competitive Landscape

Competition section of the cell line development market features profiles of key players operating in the cell line development market based on company shares, differential strategies, cell line development product offerings, marketing approach and company dashboard. Some of the key players featured in this report include Danaher Corporation, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., Lonza (Sartorius Stedim Biotech S.A.), Merck KGaA, American Type Culture Collection (ATCC), WuXi Biologics, Selexis SA.

Lonza (Sartorius Stedim Biotech S.A.) offers a range of products for cell line development, which include culture media & reagents, primary and stem cells and CellBio Services. Selexis SA has CHO-K1 cell line in their product cell line development portfolio

The key manufacturers of cell line development are focusing on novel marketing strategies to increase product penetration. Most of the companies are focusing on acquisitions, mergers, expansion, launches and agreements as the key strategies increase the sale of their cell line products in different geographies.

Definition

Cell Line Development is the procedure by which cells are developed under controlled conditions, for the most part outside their common habitat. Cell line development have variety of application in healthcare and life science industry such as drug screening, drug development, production of bio production

About the Report

Research study have been conducted on cell line development market size for the forecast period 2018 to 2028. The cell line development market report offers a comprehensive evaluation of the business opportunities prevailing in the cell line development market along with insights on the trend, market dynamics, cell line development market size opportunity analysis and cell line development market competition. The report elaborates on the macroeconomic factors influencing the dynamics of cell line development market and its futuristic potential of cell line development.

Segmentation

The report offers a comprehensive taxonomy of cell line development market based on product type, source type, end user, type of cell line and region. Cell line development products includes media and reagents, equipment and accessories. Cell lines can be derived from mammalian cell lines and non-mammalian cell lines as well. There are various cell lines available in the cell line development market such as Recombinant cell lines, hybridomas, continuous cell lines and primary cell lines. End-use segments in cell line development market which are a part of this cell line development market report include biopharmaceutical companies, contract research organizations, academics and research institutes and biotechnology companies. The cell line development market has been analyzed across regions of North America, Latin America, Europe, CIS and Russia, Asia Pacific Excluding Japan, Japan and MEA.

Additional Questions Answered

Some of the additional questions addressed in this report on cell line development market-

What is the revenue potential of care cell line development market size across regions of North America and Europe?
Who are the key competitors and what are their portfolios in cell line development market?
What are major challenges influencing the growth of cell line development market?
How intervention from regulatory authority is shaping the cell line development market growth?

Research Methodology

The cell line development market has been estimated based on supply-demand approach. A triangulation methodology is adopted to derive the market size, which is primarily based on overall expenditure on life science research and R&D funding to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on cell line development market also includes top trends and macro as well as micro economic factors shaping the cell line development market. With this approach, the report on cell line development market anticipates the industry attractiveness of every major segment in cell line development over the forecast period.

A recent market study published by FMI – “Cell Line Development Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Cell Line Development market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the Cell Line Development market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Cell Line Development market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Cell Line Development market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the Cell Line Development market report, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Cell Line Development market.

Chapter 2 – Market Introduction

Readers can find detailed taxonomy and the definition of the Cell Line Development market in this chapter, which helps readers to understand the basic information about the Cell Line Development market dynamics, supply chain, list of key distributor and suppliers, list of key market participants included in the report.

Chapter 3 – Global Cell Line Development Market Opportunity Analysis

This chapter explains how the Cell Line Development market will grow across various geographic regions, such as North America, Latin America, Europe, CIS and Russia, Asia-Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

Chapter 4 – Global Economic Outlook

This chapter explains how the global economic factors such as expenditure on health by country, global healthcare expenditure, political scenario, economic scenario and business environment can impact the cell line development market.

Chapter 5 – Market Background

Readers can find value chain of the market along with market dynamics including drivers, restraints, market opportunity and market trend.

Chapter 6 – Key Inclusions

Here in this chapter the report describes the regulatory scenario of cell line development market.

Chapter 7 – North America Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the North America Cell Line Development market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 8 – Europe Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Europe Cell Line Development market along with the country-wise assessment including the U.K., EU-4, Benelux and Rest of Europe. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 9 – CIS & Russia Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter explains the historical (2013-2017) and forecast (2018-2028) cell line development market in CIS & Russia by product, source type, cell type and end user, market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 10 – Latin America Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Latin America Cell Line Development market along with the country-wise assessment including Brazil, Mexico and Rest of Latin America. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 11 – Asia-Pacific Excluding Japan Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Asia-Pacific Excluding Japan Cell Line Development market along with the country-wise assessment including Greater China, India, ASEAN, South Korea and Rest of APEJ. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 12 – Japan Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter explains the historical (2013-2017) and forecast (2018-2028) cell line development market in Japan by product, source type, cell type and end user, market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 13 – Middle East and Africa Cell Line Development Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the Middle East and Africa Cell Line Development market along with the country-wise assessment including GCC Countries, South Africa and Rest of MEA. Readers can also find regional trends, regulations, and market growth based on product type, source type, cell type and end user. This chapter also includes market attractiveness analysis, key market participants – intensity mapping, drivers and restraints: impact analysis.

Chapter 14 – Forecast Factors: Relevance and Impact

This chapter explains the impact of different forecast factors in cell line development market.

Chapter 15 – Cell Line Development Market: Forecast Assumptions

This chapter explains the impact of different factors on cell line development market size and its relative weightage.

Chapter 16 – Cell Line Development Market: Market Structure Analysis

In this chapter readers can find detailed description of market structure by tier, market share analysis (2017) for top players, by region and product intensity mapping by key manufacturer.

Chapter 17 – Competition Analysis

This chapter includes competition dashboard, competition benchmarking, profitability and gross margin analysis by competition and company profile of key players.

Chapter 18 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 by Region

This chapter includes detailed analysis of the growth of the global Cell Line Development market along with the regional assessment including North America, Europe, CIS & Russia, Latin America, Asia Pacific Excluding Japan, Japan, Middle East and Africa. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis by region.

Chapter 19 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By Product

Based on the product type, the Cell Line Development market is segmented into Media and Reagents, Equipment and Accessories. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis based on the product type.

Chapter 20 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By Source Type

Based on the source type, the Cell Line Development market is segmented into mammalian cell line and non-mammalian cell line. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis based on the source type.

Chapter 21 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 By End User

Based on the end user type, the Cell Line Development market is segmented into Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes and Biotechnology Companies. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis by the end user.

Chapter 22 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028 by Type of Cell Lines

Based on the cell line type, the Cell Line Development market is segmented into Recombinant cell lines, Hybridomas, Continuous cell lines and Primary cell lines. In this chapter, readers can find information about key trends and developments in the Cell Line Development market and market attractive analysis by type of cell line.

Chapter 23 – Global Cell Line Development Market Analysis 2013-2017 and Forecast 2018–2028

This chapter includes market value analysis by all segment, year on year growth analysis by all segment and absolute $ opportunity

Chapter 24 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 25 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Cell Line Development market.